Imacillin 500 mg Норвегия - норвежки - Statens legemiddelverk

imacillin 500 mg

teva b.v. - amoksicillintrihydrat - tablett - 500 mg

Valganciclovir Accord 450 mg Норвегия - норвежки - Statens legemiddelverk

valganciclovir accord 450 mg

accord healthcare b.v. - valganciklovirhydroklorid - tablett, filmdrasjert - 450 mg

Augmentin 400 mg/5 ml / 57 mg/5 ml Норвегия - норвежки - Statens legemiddelverk

augmentin 400 mg/5 ml / 57 mg/5 ml

glaxosmithkline as - amoksicillintrihydrat / kaliumklavulanat - pulver til mikstur, suspensjon med fruktsmak - 400 mg/5 ml / 57 mg/5 ml

Imaxi 50 mg/ ml Норвегия - норвежки - Statens legemiddelverk

imaxi 50 mg/ ml

2care4 generics aps - amoksicillintrihydrat - pulver til mikstur, suspensjon med jordbærsmak - 50 mg/ ml

Valganciclovir Medical Valley 450 mg Норвегия - норвежки - Statens legemiddelverk

valganciclovir medical valley 450 mg

medical valley invest ab - valganciklovirhydroklorid - tablett, filmdrasjert - 450 mg

Comboval 10 mg/ ml / 3 mg/ ml Норвегия - норвежки - Statens legemiddelverk

comboval 10 mg/ ml / 3 mg/ ml

laboratoire aguettant - paracetamol / ibuprofennatriumdihydrat - infusjonsvæske, oppløsning - 10 mg/ ml / 3 mg/ ml

Zavicefta Европейски съюз - норвежки - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler for systemisk bruk, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Benzylpenicillin Panpharma 1.2 g Норвегия - норвежки - Statens legemiddelverk

benzylpenicillin panpharma 1.2 g

panpharma sa - benzylpenicillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 1.2 g

Benzylpenicillin Panpharma 0.6 g Норвегия - норвежки - Statens legemiddelverk

benzylpenicillin panpharma 0.6 g

panpharma sa - benzylpenicillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 0.6 g

Benzylpenicillin Panpharma 3 g Норвегия - норвежки - Statens legemiddelverk

benzylpenicillin panpharma 3 g

panpharma sa - benzylpenicillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 3 g